Accelerated Plasminogen Activator Dose Regimens for Coronary Thrombolysis - TAMI-7

Description:

TAMI-7 was a parallel-group, dose-ranging trial designed to evaluate safety and efficacy of several dose regimens of r-PA in fibrinolysis of acute ST elevation myocardial infarction (STEMI).